Cargando…
An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report
BACKGROUND: Pseudoxanthoma elasticum is an inherited disorder that is associated with accumulation of pathologic elastic fibers in the skin, vascular walls and Bruch’s membrane in the eye. Choroidal neovascularization is one of the most common causes of acute vision loss in these patients. We report...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866942/ https://www.ncbi.nlm.nih.gov/pubmed/24325973 http://dx.doi.org/10.1186/1756-0500-6-530 |
_version_ | 1782296246693658624 |
---|---|
author | Karampelas, Michael Soumplis, Vasileios Karagiannis, Dimitrios Parikakis, Efstratios Webster, Andrew R |
author_facet | Karampelas, Michael Soumplis, Vasileios Karagiannis, Dimitrios Parikakis, Efstratios Webster, Andrew R |
author_sort | Karampelas, Michael |
collection | PubMed |
description | BACKGROUND: Pseudoxanthoma elasticum is an inherited disorder that is associated with accumulation of pathologic elastic fibers in the skin, vascular walls and Bruch’s membrane in the eye. Choroidal neovascularization is one of the most common causes of acute vision loss in these patients. We report an atypical case of suspected choroidal neovascularization associated with pseudoxanthoma elasticum. CASE PRESENTATION: A 47-year-old Caucasian woman with pseudoxanthoma elasticum and angioid streaks was referred because of decreased and distorted vision in her right eye of one week’s duration. Visual acuity was 6/12 in the right eye and 6/6 in the left eye. Fundus examination revealed angioid streaks and white intraretinal macular deposits bilaterally. Fluorescein angiography did not reveal any obvious leakage in the right eye while optical coherence tomography revealed subretinal fluid associated with an adjacent intraretinal hyperreflective structure. Autofluoresence imaging showed focal areas of increased autofluorescence corresponding to the deposits in both eyes. Over the following year the patient underwent five intravitreal injections of bevacizumab (Genentech/Roche,US) in the right eye, which resulted in visual acuity improving to 6/9 with regression of the hyperreflective structrure and complete resolution of subretinal fluid. CONCLUSIONS: Traditionally, fluorescein angiography is effective in the detection of choroidal neovascularization in patients with pseudoxanthoma elasticum. In our case, optical coherence tomography revealed subretinal fluid and an adjacent hyperreflective structure while fluorescein angiography did not reveal any obvious leakage. The sole presence of subretinal fluid does not necessarily imply the presence of choroidal neovascularization and certainly retinal pigment epithelium dysfunction could also explain subretinal fluid in these patients. However, the complete absorption of the fluid and the disappearance of the previously evident hyperreflective structure following treatment, led us to suspect choroidal neovascularization as the primary cause of the above findings. The poor natural course of choroidal neovascularization in these patients increases the importance of early detection and should result in the adaptation of a low-threshold strategy concerning the initiation of treatment. |
format | Online Article Text |
id | pubmed-3866942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38669422013-12-19 An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report Karampelas, Michael Soumplis, Vasileios Karagiannis, Dimitrios Parikakis, Efstratios Webster, Andrew R BMC Res Notes Case Report BACKGROUND: Pseudoxanthoma elasticum is an inherited disorder that is associated with accumulation of pathologic elastic fibers in the skin, vascular walls and Bruch’s membrane in the eye. Choroidal neovascularization is one of the most common causes of acute vision loss in these patients. We report an atypical case of suspected choroidal neovascularization associated with pseudoxanthoma elasticum. CASE PRESENTATION: A 47-year-old Caucasian woman with pseudoxanthoma elasticum and angioid streaks was referred because of decreased and distorted vision in her right eye of one week’s duration. Visual acuity was 6/12 in the right eye and 6/6 in the left eye. Fundus examination revealed angioid streaks and white intraretinal macular deposits bilaterally. Fluorescein angiography did not reveal any obvious leakage in the right eye while optical coherence tomography revealed subretinal fluid associated with an adjacent intraretinal hyperreflective structure. Autofluoresence imaging showed focal areas of increased autofluorescence corresponding to the deposits in both eyes. Over the following year the patient underwent five intravitreal injections of bevacizumab (Genentech/Roche,US) in the right eye, which resulted in visual acuity improving to 6/9 with regression of the hyperreflective structrure and complete resolution of subretinal fluid. CONCLUSIONS: Traditionally, fluorescein angiography is effective in the detection of choroidal neovascularization in patients with pseudoxanthoma elasticum. In our case, optical coherence tomography revealed subretinal fluid and an adjacent hyperreflective structure while fluorescein angiography did not reveal any obvious leakage. The sole presence of subretinal fluid does not necessarily imply the presence of choroidal neovascularization and certainly retinal pigment epithelium dysfunction could also explain subretinal fluid in these patients. However, the complete absorption of the fluid and the disappearance of the previously evident hyperreflective structure following treatment, led us to suspect choroidal neovascularization as the primary cause of the above findings. The poor natural course of choroidal neovascularization in these patients increases the importance of early detection and should result in the adaptation of a low-threshold strategy concerning the initiation of treatment. BioMed Central 2013-12-11 /pmc/articles/PMC3866942/ /pubmed/24325973 http://dx.doi.org/10.1186/1756-0500-6-530 Text en Copyright © 2013 Karampelas et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Karampelas, Michael Soumplis, Vasileios Karagiannis, Dimitrios Parikakis, Efstratios Webster, Andrew R An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title | An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title_full | An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title_fullStr | An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title_full_unstemmed | An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title_short | An atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
title_sort | atypical case of choroidal neovascularization associated with pseudoxanthoma elasticum treated with intravitreal bevacizumab: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866942/ https://www.ncbi.nlm.nih.gov/pubmed/24325973 http://dx.doi.org/10.1186/1756-0500-6-530 |
work_keys_str_mv | AT karampelasmichael anatypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT soumplisvasileios anatypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT karagiannisdimitrios anatypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT parikakisefstratios anatypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT websterandrewr anatypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT karampelasmichael atypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT soumplisvasileios atypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT karagiannisdimitrios atypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT parikakisefstratios atypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport AT websterandrewr atypicalcaseofchoroidalneovascularizationassociatedwithpseudoxanthomaelasticumtreatedwithintravitrealbevacizumabacasereport |